Detalhe da pesquisa
1.
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Lancet Oncol
; 25(6): 779-789, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701815
2.
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Mod Pathol
; 37(3): 100423, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191122
3.
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
Int J Gynecol Cancer
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649234
4.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Br J Cancer
; 128(7): 1360-1368, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690721
5.
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
BMC Cancer
; 23(1): 541, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312053
6.
Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis.
Acta Oncol
; 62(11): 1479-1487, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906286
7.
Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma.
Acta Oncol
; 62(1): 40-47, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576773
8.
ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
Int J Gynecol Cancer
; 33(6): 862-875, 2023 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258414
9.
ESTRO/ESGO/SIOPe Guidelines for the management of patients with vaginal cancer.
Int J Gynecol Cancer
; 33(8): 1185-1202, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336757
10.
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
Int J Gynecol Cancer
; 33(5): 649-666, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37127326
11.
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment.
Gynecol Oncol
; 164(3): 577-586, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078648
12.
Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
Int J Gynecol Pathol
; 41(3): 227-234, 2022 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392268
13.
Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer.
Int J Gynecol Pathol
; 41(3): 220-226, 2022 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261899
14.
Drug repurposing as a potential source of innovative therapies in cervical cancer.
Int J Gynecol Cancer
; 2022 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137575
15.
Vaginal brachytherapy management of stage I and II endometrial cancer.
Int J Gynecol Cancer
; 32(3): 304-310, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256416
16.
Patient-derived breast model repository, a tool for hyperthermia treatment planning and applicator design.
Int J Hyperthermia
; 39(1): 1213-1221, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104074
17.
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Lancet Oncol
; 22(4): 538-547, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794207
18.
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
Cancer
; 127(14): 2409-2422, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793971
19.
Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.
Gynecol Oncol
; 163(1): 117-124, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301412
20.
Uterine serous carcinoma.
Gynecol Oncol
; 162(1): 226-234, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934848